CDK9 and breast carcinoma: Estrogen positive breast cancer cells were found to be very sensitive to CDK9 inhibitors and at a sub-nanomolar concentration of CDK9 inhibitor, the cell undergoes apoptosis associated with a several-fold downregulation of c-MYB expression.